A New Frontier: A Virtual Grand Rounds Series Examining Novel Targets and Personalized Strategies to Improve Outcomes in Major Depressive Disorder

July 29, 2025

Program Description

EfficientCME’s Virtual Grand Rounds series offers a modern, accessible alternative to traditional in-person education—delivering high-impact, case-based learning directly to busy clinicians. These live, interactive sessions focus on excessive daytime sleepiness (EDS) and bipolar depression (BD), using small-group formats and interprofessional collaboration to promote meaningful changes in clinical practice. Led by expert faculty, each session blends evidence-based insights with peer perspectives to support real-world decision-making. Proven effective and highly rated by participants, this virtual model removes common barriers to attendance and enhances learner engagement across diverse healthcare settings.

Target Audience

This activity is designed to meet the needs of primary care physicians, nurse practitioners, physician assistants, registered nurses, and other healthcare professionals involved in the diagnosis and long-term management of patients with MDD.

Learning Objectives

Upon completion of this activity, the learner should be able to:

  • Address the modern understanding of MDD pathology and its relationship to available treatments
  • Evaluate new and emerging treatment strategies for MDD to determine their current or future roles
  • Develop evidence-based approaches to switching, combining, or augmenting pharmacotherapy based on individual patient presentations
Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Attendance
Course opens: 
07/17/2025
Course expires: 
08/05/2025
Event starts: 
07/29/2025 - 1:00pm EDT
Event ends: 
07/29/2025 - 2:00pm EDT
Cost:
$0.00
Add to calendar: 
Rating: 
0

   Joseph F. Goldberg, MD
   Icahn School of Medicine at Mount Sinai

 

 

 

   Anita H. Clayton, MD
   University of Virginia School of Medicine

 

 

 

   Manish K. Jha, MD
   UT Southwestern Medical Center

 

 

 

   Roger McIntyre, MD, FRCPC
   University of Toronto

 

 

 

   Michael E. Thase, MD
   University of Pennsylvania

This activity is jointly provided by Medical Education Resources (MER) and Efficient LLC. 

image               image     

Joint Accreditation Statement

image

In support of improving patient care, this activity has been planned and implemented by Medical Education Resources (MER) and Efficient LLC. MER is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Designation Statement

PHYSICIAN CREDIT
Medical Education Resources designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
 
CERTIFICATE OF PARTICIPATION FOR OTHER HEALTHCARE PROFESSIONALS
A Certificate of Participation will be given upon completion of the enduring activity enabling participants to register their credit with the appropriate licensing boards or associations.

Staff Disclosures

Efficient LLC and Medical Education Resources' planners and managers have no financial relationships to disclose.

Faculty Disclosures

  • Dr. Goldberg reports the following relationships: Consultant: AbbVie, Alvogen, Genomind, Luye Pharmaceuticals, Neumora, Otsuka, Sunovion; Speaker's Bureau: Alkermes, Axsome, Bristol Meyers Squibb, intracellular Therapies
  • Dr. Clayton reports the following relationships: Consultant: AbbVie, Inc, Actinogen, AdhereTech, Axsome Therapuetics, Biogen, Inc., Fabre-Kramer Pharmaceuticals, Initiator Pharma, Intra-cellular Therapies, Janssen, LIVANOVA PLC,  MycoMedica Life Sciences, PBC, Neumora Therapeutics, Inc., Neurocrine Biosciences, P/S/L Group Services, Reunion Neuroscience, Inc., Seaport Therapeutics, S1 Biopharma, Sirtsei Pharmaceuticals, Inc., Vella Bioscience, Inc.; ​Grants: Janssen, Neumora Therapeutics, Neurocrine Biosciences, Otsuka, Relmada Therapeutics, Inc., Reunion Neuroscience, Inc., S1 Biopharma; Royalties/Copyright: Ballantine Books/Random House, Changes in Sexual Functioning Questionnaire, Guilford; Publications​ Shares/Restricted Stock Units: Mediflix LLC, S1 Biopharma​ 
  • Dr. Jha reports the following relationships: Contract Research: Janssen, Navitor, Neurocrine Biosciences; Consultant: Boehringer Ingelheim, Janssen; Chair of DSMB: IQVIA, Worldwide Clinical Trials, Vicore Pharma
  • Dr. McIntyre reports the following relationships: Grants: CIHR/GACD/National Natural Science Foundation of China (NSFC) and the Milken Institute; Consultant: Lundbeck, Janssen, Alkermes, Neumora Therapeutics, Boehringer Ingelheim, Sage, Biogen, Mitsubishi Tanabe, Purdue, Pfizer, Otsuka, Takeda, Neurocrine, Neurawell; Speaker: Sunovion, Bausch Health, Axsome, Novo Nordisk, Kris, Sanofi, Eisai, Intra-Cellular, NewBridge Pharmaceuticals, Viatris, Abbvie and Atai Life Sciences.  
  • Dr. Thase reports the following relationships: Advisory Board/Consulting Fees: AbbVie, Inc, Actinogen, AdhereTech, Axsome Therapuetics, Biogen, Inc., Fabre-Kramer Pharmaceuticals, Initiator Pharma, Intra-cellular Therapies,  Janssen, LIVANOVA PLC, MycoMedica Life Sciences, PBC, Neumora Therapeutics, Inc., Neurocrine Biosciences, P/S/L Group Services, Reunion Neuroscience, Inc., Seaport Therapeutics, S1 Biopharma, Sirtsei Pharmaceuticals, Inc., Vella Bioscience, Inc.;​ Grants: Janssen, Neumora Therapeutics, Neurocrine Biosciences, Otsuka; Relmada Therapeutics, Inc., Reunion Neuroscience, Inc., S1 Biopharma; ​ Royalties/Copyright: Ballantine Books/Random House, Changes in Sexual Functioning Questionnaire, Guilford Publications​; Shares/Restricted Stock Units: Mediflix LLC, S1 Biopharma​​ 

Disclosure of Relevant Financial Relationships

Medical Education Resources ensures balance, independence, objectivity, and scientific rigor in all our educational activities. In accordance with this policy, MER identifies all financial relationships with its instructors, content managers, and other individuals who are in a position to control the content of an activity. Reported relevant financial relationships are mitigated by MER to ensure that all scientific research referred to, reported, or used in a CE activity conforms to the generally accepted standards of experimental design, data collection, and analysis. MER is committed to providing learners with high-quality CE activities that promote improvements or quality in health care and not the business interest of an ineligible company.

All relevant conflicts of interest have been mitigated prior to the start of the activity.
Efficient LLC and Medical Education Resources' planners and managers have no financial relationships to disclose. 

Disclaimer

The content and views presented in this educational activity are those of the authors and do not necessarily reflect those of Medical Education Resources, Efficient LLC, and/or AbbVie, Axsome Therapeutics, or Intra-Cellular Therapies. The authors have disclosed if there is any discussion of published and/or investigational uses of agents that are not indicated by the FDA in their presentations. Before prescribing any medicine, primary references and full prescribing information should be consulted. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. The information presented in this activity is not meant to serve as a guideline for patient management.

Commercial Support

This activity is supported by educational grants from AbbVie, Axsome Therapeutics, and Intra-Cellular Therapies.

Media

Internet

Available Credit

  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Attendance

Price

Cost:
$0.00
Please login or register to take this course.